The setup heading into Thursday's report is mixed-to-cautious: AXON has recovered sharply from its October low of $377 but remains in a moderate 100-day downtrend, sitting 42% below its 52-week high while facing a negative analyst revision trend — yet the options market is leaning bullish and the fundamental growth story remains intact at +32% revenue guidance.
The Setup: A Bounce Looking for Confirmation
Axon Enterprise closed Monday at $425.43, up roughly 12.8% from its October 19 low of $377 but still sitting 3.3% below the recent intraday high of $439.76 reached on November 2. The five-day trend is effectively flat, the 20-day trend is modestly upward (+1.6% slope), and the 100-day trend remains a moderate downtrend with the stock trading below its long-run mean — a structurally bearish backdrop despite the recent bounce.
The 50-day simple moving average sits at $459.62, well above the current price, confirming that the recovery from the October selloff has not yet reclaimed any major intermediate trend line. The 20-day SMA at $414.91 now serves as near-term dynamic support. Momentum is recovering (RSI at 53.1), but the stock needs a strong earnings print to break the pattern of lower highs.
One headline worth noting: a recent article flagged that Axon is 42% off its 52-week high, with the November 5 report needing to demonstrate "really attractive growth" to justify a re-rating. That framing captures the binary nature of this setup — the stock is discounting bad news, but it also needs a catalyst to reverse the multi-month trend.
What the Options Market Says
Options flow into earnings is scoring a 71 out of 100 — firmly in accumulation territory — and the MACD signal on the flow is bullish. The gamma wall structure places the call wall at $500 (2,169 contracts of open interest) and the put wall at $400 (1,951 contracts), forming a corridor that dealer positioning suggests will act as magnetic boundaries for any post-earnings reaction.
The most significant pre-earnings options positioning is a notable build of 5,000 contracts of open interest at the $470 call strike — a level roughly 10.5% above current price. That accumulation suggests some participants are positioning for a meaningful upside move, consistent with the bullish gamma bias reading. On the downside, put open interest is concentrated at lower strikes — $355, $345, and $320 — indicating the market sees those levels as tail-risk hedges rather than near-term targets.
The options signal confidence is rated LOW, and the put/call ratio (PC ratio score of 65) reflects meaningful two-way hedging activity. With the stock carrying a forward P/E of 42.6x and a trailing P/E of 177.5x, any guidance miss or margin disappointment could trigger a sharp de-rating. The $400 put wall is only 6% below current price — a level that could be tested quickly on a weak report.
Fundamentals & Estimates
The Wall Street consensus for Q3 2026 calls for EPS of $1.89 (range: $1.22–$2.46) against year-ago EPS of $1.17, implying year-over-year growth of approximately 62%. Revenue consensus is $937 million (range: $908M–$960M), representing 31.9% growth versus the year-ago quarter's $711 million. These are strong absolute numbers — the challenge is that Axon has already raised its full-year 2026 revenue growth guidance to 32%–34%, so the bar is set high.
For the full year, analysts expect $7.64 in EPS and $3.71 billion in revenue (+33.5% YoY). Looking to 2027, estimates call for EPS of $10.51 (+37.6% growth) on revenue of $4.80 billion — suggesting the market is pricing in an extended high-growth run.
The analyst community is broadly constructive: 18 Buy/Strong Buy ratings versus just 3 Holds and zero Sells. The mean price target of $680.37 implies 59.9% upside from current levels. However, the revision trend is a yellow flag — over the past 30 days, analysts have issued 8 EPS downward revisions versus only 4 upward revisions, a net negative signal that reflects some trimming of near-term expectations. The current-year EPS estimate has slipped from $7.72 ninety days ago to $7.64 today.
From a valuation standpoint, Axon's forward P/E of 42.6x and PEG ratio of 1.54 are not cheap, but they are defensible if the company can sustain 30%+ revenue growth. Profit margins remain thin at 6.2%, and ROE stands at the same level, meaning execution on the path to durable profitability will be closely scrutinized in the earnings call.
On the supply chain and competitive moat front, Axon occupies a sensors and edge-devices position within the Physical AI supply chain with a bottleneck score of 7 out of 10, reflecting its network-effect moat — the Axon ecosystem of body cameras, TASER devices, and cloud evidence management is deeply embedded with law enforcement customers including the LAPD, NYPD, FBI, and international agencies. That structural stickiness provides revenue visibility that pure-software peers lack.
Key Levels to Watch
| Level | Price | Significance |
|---|---|---|
| Call Wall (Gamma) | $500 | Major dealer resistance; upside magnet on a strong beat |
| Key Call OI Build | $470 | 5,000-contract OI accumulation; first upside target on beat |
| Recent Resistance | $439.76 | 20-day high; must reclaim to confirm trend reversal |
| 50-Day SMA | $459.62 | Intermediate trend line; reclaiming this would be meaningfully bullish |
| Current Price | $425.43 | Last close (Nov 2) |
| 20-Day Support | $413.18 | Near-term dynamic floor; a close below this would be bearish |
| 100-Day Support | $403.49 | Longer-term structural support |
| Put Wall (Gamma) | $400 | Dealer-defined downside floor; breach would open air to ~$355 |
If Axon misses revenue or guides below the 32%–34% growth range, the $400 put wall becomes the first test. A sustained break below $400 — less than 6% from current levels — would remove the nearest structural support and open a potential move toward the $355–$345 zone where tail-risk put hedges are concentrated. The stock is already below its 50-day and 100-day moving averages, so there is limited technical cushion.
Bottom Line
Axon heads into its Q3 report in a position where the fundamentals are strong — 62% expected EPS growth, 32% revenue growth, an 18-analyst Buy consensus, and a network-effect moat rated 7/10 — but the technicals are mixed and the revision trend is modestly negative. The options market is leaning bullish (flow score 71/100, call-side OI building at $470), which suggests informed participants are positioned for an upside surprise. If the company meets or beats the $1.89 EPS / $937M revenue consensus and reaffirms full-year guidance, the path toward $470–$500 opens. A miss or guidance cut, however, puts the $400 put wall directly in play. Given the low setup-quality score and the stock's distance below its 50-day moving average, a beat-and-raise is needed — not just a beat — to sustain a meaningful post-earnings rally.
This article was generated by Tradestie Alpha Assistant using live market data (investment scores, options positioning, trendlines, and fundamentals) and reviewed before publication. It is for informational purposes only and is not financial advice. Do your own research before making investment decisions.